Who is sponsoring ESCIHP?

ESCIHP is sponsored by Xiyuan Hospital of China Academy of Chinese Medical Sciences.

What condition does ESCIHP study?

ESCIHP studies Hypertension,Essential.

What drugs are being tested in ESCIHP?

Interventions: Songling Xuemaikang Capsules, Lifestyle intervention, Placebo.

What is the status of ESCIHP?

ESCIHP is currently RECRUITING.

Last reviewed 2024-08-17 · How we verify

Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized, Multicenter, Double-blind, Placebo-controlled Trial (ESCIHP)

NCT06093932 Phase 4 RECRUITING

The purpose of this study is: 1. To evaluate the efficacy of Songling Xuemaikang Capsules(SLXMKC) with grade 1 hypertension. 2. To reveal the potiential effects of SLXMKC on vascular function and structure of patients with grade 1 hypertension. 3. To explore the underlying mechanisms of the therapeutic effects of SLXMKC on the intervention of grade 1 hypertension.

Details

Lead sponsor	Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase	Phase 4
Status	RECRUITING
Enrolment	100
Start date	2024-04-07
Completion	2027-12

Conditions

Hypertension,Essential

Interventions

Songling Xuemaikang Capsules
Lifestyle intervention
Placebo

Primary outcomes

Change from Baseline in the Mean 24h Systolic Blood Pressure at 4,12 weeks — Baseline and Week 4,12
Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value)

Countries

China